BrainStorm Cell Therapeutics
BCLI
#10943
Rank
NZ$16.7 M
Marketcap
NZ$1.51
Share price
-3.33%
Change (1 day)
26.89%
Change (1 year)

Cost to borrow BCLI shares - BrainStorm Cell Therapeutics

Latest borrow fee for BrainStorm Cell Therapeutics (BCLI) shares on Interactive Brokers: 15.9219% (annualized)

Shares available to borrow: 400000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

BrainStorm Cell Therapeutics (BCLI) - cost to borrow in the last 7 days chart

BrainStorm Cell Therapeutics (BCLI) - number of shares available to borrow in the last 7 days

BrainStorm Cell Therapeutics (BCLI) - cost to borrow from 2026 to 2023

BrainStorm Cell Therapeutics (BCLI) - number of shares available to borrow from 2026 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
Biogen
BIIB
0.2505%1.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
0.4081%9.6 M๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
0.25%2.2 M๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
0.3256%1.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
0.8821%1.4 M๐Ÿ‡บ๐Ÿ‡ธ USA